Research firm GoodFirms said on Thursday that the hospitals are adapting various healthcare software to maintain and manage the records to reduce the viral transmission between patients and providers via the exchange of files or prescriptions during the COVID-19 crisis.
In the face of COVID-19, most healthcare departments, pharmacy companies and medical practice institutes have invested in software to keep the information confidential and secure and make it easier to get the data in just one click.
However, various health professionals and healthcare facility providers are facing challenges to pick the right tool. Therefore, GoodFirms.co has evaluated a list of Medical Practice Management, Medical Transcription, Mental Health, Chiropractic, Child Care, Dental Practice, Electronic Medical Records and Hospital Management Software.
The firm is providing Best Medical Practice Management Software, Best Medical Transcription Software, Best Mental Health Software, Best Chiropractic Management Software, Best Child Care Software, Best Dental Practice Software, Best Electronic Medical Records Software as well as Best Hospital Management Software to increase productivity and earn more revenue during the pandemic.
UCB reports positive Phase 3 results for fenfluramine in CDKL5 deficiency disorder
WuXi AppTec's Nantong site receives 2025 Architizer A+Award
MGI partners with Negedia to enhance genomic sequencing in Italy
Speranza Therapeutics partners with Sunshine Labs for harm reduction solutions
CARsgen Therapeutics' satri-cel NDA accepted by Chinese regulator
Sanofi receives FDA orphan drug designation for riliprubart in transplant rejection
Aptamer Group signs development and licensing deal with global life sciences partner
Scancell expands Phase 2 SCOPE trial with new intradermal dosing arm for iSCIB1+
Telix Pharmaceuticals delivers first commercial doses from Belgian manufacturing hub
CivicaScript introduces low-cost multiple sclerosis treatment
Innovent presents mazdutide Phase 3 clinical study results at ADA 85th Scientific Sessions
Hoth Therapeutics reports positive interim results for HT-001 topical therapy
Hemab Therapeutics presents bleeding disorder clinical and preclinical data at ISTH 2025 Congress